The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for ...

The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.

Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...

The FDA recently approved Vertex Pharmaceuticals Incorporated’s Journavx (suzetrigine), a first-in-class non-opioid medication for treating moderate to severe acute pain in adults. Journavx, approved ...

The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

The medication offers relatively modest pain relief, underscoring the challenges of finding new ways to manage pain.

It was given to people who had acute surgical pain from either abdominoplasty, also known as a tummy tuck, or bunion surgery.

Introducing Journavx as a Safe Opioid Alternative for Pain Relief"** In a notable development, the FDA has granted approval for Journavx, positioning it as a viable alternative to opioids for pain ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...